They have first verified that the phenotypes of infiltrating T cells and mechanisms of ICB are indeed tumor-type-independent, and anti-CTLA-4-induced and anti-PD-1-induced anti-tumor responses are driven by distinct cellular mechanisms. Here, CTLA4 is linked to neoplasm.